Investment Q&A

Q: I currently own BMO Asian Growth and Income GGF734 and wonder what are your thoughts of selling this fund and buying VA instead?
Thanks

Q: When will Photon release next quarterly report?

Q: I note you think the offer for AVO is modest but the text I have suggests the deal has been done. So is this the case or is there the potential for another higher offer? I also note that the volume of shares sold so far is quite light which might indicate most people think there could be another offer or that the price is low?

Q: In response to Donald, it appears ok to pay RRSP fees outside the RRSP as of right now. However, the CRA is currently reviewing this rule and says that may no longer be the case as of January 1, 2019. A Google search of "rrsp fees paid outside rrsp" will bring up many discussions on this topic.

Q: Hello
Can you comment on Saputo earnings?

Thank you
Stephane

Q: Good Morning team,
How do you interpret this quarters financial results?Andrew

Q: Here is a quote that may help those of us who are getting impatient with Knight Therapeutics:
"It takes character to sit with all that cash and to do nothing. I didn’t get
to where I am by going after mediocre opportunities.” – Charlie Munger

Q: I have a question about Avigilon:
Do you think the Motorola buyout of AVO is fair to shareholders? Would you sell your shares now or just wait for more info, a competing bid, or for the deal to go through?

Q: Financial planners management fees of 1% are taken within my TFSA, RRIF accounts. This diminishes the balance in these accounts. Is it possible to have them paid outside of the TFSA and RRIF?

Q: Could you please provide US names similar to wsp and stn, or other companies to benefit from infrastructure expansion in the US? Many thanks, great service!

Rob

Q: Hi 5i Team,
Can you please comment on Rogers Sugar's earnings release today? There are so many adjustments to their numbers that I find it difficult to gauge how good a quarter it was. I hold this stock primarily for income. Can you please comment on the safety/ability to grow the dividend, and free cash flow trend over the past few quarters?
Many thanks,
Brian

Q: Good evening,

Multi-part question.

Had just finished reading ‘The Little Book of common sense Investing’, decide to make the switch, and am beginning to plan my transition to CPD, ZAG, VFV, XEF, VCN, VEE, and XRE, when I come across the new Vanguard products, of which VBAL to me seems the most interesting.

I see the pros of this ETF as being straightforward and dropping from 7 commission fees (re-balancing myself), vs just one trade a year to add money (portfolio currently around $26,000).

Cons: no preferreds or real estate. Less control (e.g they decide the asset allocations).

Do you have an opinion on this ETF?

Not sure the yield on VBAL but am guessing 2.5-3% maybe? Any idea?

Also, If I go ahead with VBAL would you give it some time to settle down (trading looks a little erratic), or is that volatility purely a product of price changes of its holdings already?

Thanks!

Q: I see the sector is down the last few days, but MET has seemed to drop more in share value than SLF, & AIG,. Do you know of any reason for this and are you still positive in regards to MET. I am aware you don't follow the US market that closely. Also, if you are allowed, the report date of SPE.TO, CEU.TO, & WCP.TO. Thanks

Q: Hello 5i Team,

little bit of a two for one here though all three of these companies in my portfolio are in the same battered sector. Obviously the Canadian natural gas producers are hurting right now due to weak prices, an oversupply, and a lack of pipeline to deliver especially in Alberta but Peyto itself has really bled out over the last 6 months. The dividend is nice but of course was cut and I'm feeling uncertain as to whether it will continue to be sustainable and even if the loss in stock value is very much offsetting it. Do you see any upside here? The strong downward trend momentum is rather discouraging.

Cenovus and Trican are two others that I recently acquired at the higher end of the scale relative to the last month. Since then they've been steadily sliding especially Cenovus and I presume this is due to rising bond yields, higher interest rates, and a lack of sentiment towards the energy sector. Could you please give me your thoughts on them over the short and long term please? Thanks a bunch! Your guidance is very much appreciated.

Q: ALY and KAT, two unrelated stocks, seem to be plunging. Has the story changed for them both, or is at least one worth holding on to? Any thoughts on their balance sheets? Thanks for your advice.

Q: Is it time to revisit Ten Peaks? What do you think of as an investment today? It looks good from a technical standpoint and pays an o.k. dividend.

Q: Cheers. First of all thanks for recent Avo encouragement. Worked out very well.

What are the consequences to Gud if companies like Amazon get into the pharmaceutical business in a big way? Also there is lots of talk by governments and insurance companies of signing contracts with drug providers where drug costs are lowered by 35-40%. Quebec signed such a contract awhile ago and recent reports suggest the other provinces are also in the process of doing so. I believe this is the area where Jonathan Goodman and his team have their expertise and previous success. I have a 3 year invested interest in Gud and wondering how these events are affecting Guds future potential and even its present share price decline?
Would like to hear your valued thots on this.
Thanks
Terry

Q: We're now $1900 underwater on 800 shares of KEY. Any hope for the future? Sell, hold buy? These are troubled times ! Many thanks - Ted

Q: together these 5 stocks make up 10% of my portfolio. not a terribly large weighting but enough that i have felt the recent decline. I understand the correlation between interest rates and these companies that are viewed as bond proxies. Since Jan 1 2018 BCE is down 5.5%, BEP is down 7%, BIP is down 8%, TRP down over 9%, ENB down over 10% (all return % are excluding dividends). ENB is now yielding over 6% if their Q1 2018 dividend is extrapolated for the FY 2018. my question is at what point does one consider the decline overdone and step into one or a few of these? a 6% yield on ENB is looking attractive to me but do you think there is still more downside risk in these names?

Q: ILMN gave non GAAP projections of about 13% earnings growth for 2018. About $4.55 from $4.00. This seems somewhat meagre. Do you know if they are generally cautious with their numbers historically? I like their business but do not know quite how to take this information of seemingly slower growth. Are the hedging expectations overly?